Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design.

Res Pharm Sci · 2015 · PMC4578209 · PMID 26430454

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

almost insignificantno p-value reported

Some of the variables from Taguchi design were found almost insignificant and were, therefore, excluded from the Box-Behnken design.

also in 529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.